Literature DB >> 30474527

Enhanced Vitamin K (Menaquinone-7) Production by Bacillus subtilis natto in Biofilm Reactors by Optimization of Glucose-based Medium.

Ehsan Mahdinia1, Ali Demirci1, Aydin Berenjian2.   

Abstract

BACKGROUND: Benefits of vitamin K have been reported by many studies recently, due to its ability to reduce the risk of cardiovascular diseases and its potential benefits against osteoporosis. Specifically, menaquinone-7 (MK-7), being the most potent form of vitamin K, has definitely received most of the attention. Currently, solid or static liquid fermentation strategies are utilized for industrial production of MK-7 by Bacillus strains. However, these strategies face fundamental operational and scale-up issues as well as intense pellicle and biofilm formations which is problematic in static liquid fermentation, due to heat and mass transfer inefficiencies they create.
OBJECTIVE: The purpose of this study was to demonstrate that biofilm reactors will overcome the issues associated with suspended cell reactors when using Bacillus strains to produce MK-7. The expectation is that the use of biofilm reactors will result in a significant increase in the production of MK-7.
METHOD: Vitamin K production by Bacillus subtilis natto when grown in a biofilm reactor was evaluated at various concentrations of the three major nutrients, glucose, yeast extract and casein. The data was analyzed using response surface methodology (RSM).
RESULTS: The maximum concentration of MK-7 in the biofilm reactors was 20.5±0.5 mg/L, which was a 344 % increase when compared to the amount produced in suspended-cell reactors containing the same optimum media composition.
CONCLUSION: These results demonstrate the potential of utilizing biofilm reactors for MK-7 production on an industrial scale. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Bacillus subtilis; MK-7; RSM optimization; biofilm reactor; glucose medium; menaquinone-7; vitamin K.

Mesh:

Substances:

Year:  2018        PMID: 30474527     DOI: 10.2174/1389201020666181126120401

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  2 in total

1.  Phytogenic products, used as alternatives to antibiotic growth promoters, modify the intestinal microbiota derived from a range of production systems: an in vitro model.

Authors:  Yadav S Bajagai; Jenifer Alsemgeest; Robert J Moore; Thi T H Van; Dragana Stanley
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-12       Impact factor: 4.813

Review 2.  Production of Vitamin K by Wild-Type and Engineered Microorganisms.

Authors:  Min-Ji Kang; Kwang-Rim Baek; Ye-Rim Lee; Geun-Hyung Kim; Seung-Oh Seo
Journal:  Microorganisms       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.